Shots:
The NMPA has approved ciprocopan (NXP100, QD, PO) for the treatment of pts with PNH previously untreated with Complement inhibitors. Application for PNH pts previously treated with anti-C5 therapies is under review in China
Approval was based on a P-III trial of ciprocopan vs Soliris in the above-mentioned pts, which met all 1 &…
